ANVS logo.jpg
Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations
02 oct. 2024 08h30 HE | Annovis Bio, Inc.
NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Annovis Bio Inc. (NYSE: ANVS) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+ brands...
UsAgainstAlzheimer’s
UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi for Treatment of Early-Stage Alzheimer’s
06 juil. 2023 17h35 HE | UsAgainstAlzheimer's
Washington, DC, July 06, 2023 (GLOBE NEWSWIRE) -- Patient advocacy organization UsAgainstAlzheimer’s today hailed the first-of-its-kind traditional approval by the Food and Drug Administration (FDA)...
Global Alzheimer’s P
Global Alzheimer’s Platform Foundation (GAP) President Blasts CMS’ “Unprecedented and Pernicious” Discrimination Against People with Alzheimer’s Disease
23 févr. 2023 08h51 HE | Global Alzheimer's Platform Foundation
Washington, D.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Statement by Global Alzheimer’s Platform Foundation® President John Dwyer: “Once again, the Centers for Medicare and Medicaid Services (CMS) has...